Englewood Health is an acute care 289-bed teaching hospital in Englewood, New Jersey. In 2021 it was given a grade A by the Leapfrog patient safety organization.

There are 289 beds in Englewood Hospital and Medical Center.

During the past decade, Englewood Hospital and Medical Center conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 48 clinical trials were completed, i.e. on average, 55.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 30 clinical trials were completed. i.e. 107.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Englewood Hospital and Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Englewood Hospital and Medical Center" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "Abbott Medical Devices" with 9 trials sponsored and "Boston Scientific Corporation" with 9 trials sponsored. Other sponsors include 69 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Englewood Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "Englewood Hospital and Medical Center" are "Breast Cancer" (10 trials), "Atrial Fibrillation" (7 trials), "Coronary Artery Disease" (6 trials), "Breast Adenocarcinoma" (5 trials) and "Coronary Disease" (4 trials). Many other conditions were trialed in "Englewood Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Englewood Hospital and Medical Center" are "Drug" (77 trials), "Other" (49 trials), "Device" (34 trials), "Biological" (22 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (15 trials), "Placebo" (11 trials), "Paclitaxel" (9 trials) and "Questionnaire Administration" (7 trials). Other intervention names were less common.

The vast majority of trials in "Englewood Hospital and Medical Center" are 117 trials for "All" genders and 21 trials for "Female" genders.

Currently, there are NaN active trials in "Englewood Hospital and Medical Center". undefined are not yet recruiting, 23 are recruiting, 33 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 52 completed trials in Englewood Hospital and Medical Center, 1 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Englewood Hospital and Medical Center, 2 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 42 trials that are defined as “Not Applicable".

Englewood Hospital and Medical Center has several departments that took part in Clinical trials: "Dizzy Gillespie Cancer Institute at Englewood Hospital and Medical Center" - 9 trials